RFK-appointed CDC panel drops hepatitis B vaccine at birth recommendation

Key Concepts

• Hepatitis B vaccine
• Newborn vaccination
• Advisory Committee for Immunization Practices (ACIP)
• Robert F. Kennedy Jr.
• Liver disease (cirrhosis, liver cancer)
• Blood-borne virus
• Transmission of Hepatitis B
• Autism and vaccines
• Thimerosal
• MMR vaccine
• Tylenol
• Chickenpox vaccine
• Pharmaceutical company liability
• Federal regulators
• American Academy of Pediatrics (AAP)
• Centers for Disease Control and Prevention (CDC)

Hepatitis B Vaccine Recommendation Change

The federal government's vaccine advisory panel, appointed by Health Secretary Robert F. Kennedy Jr., has voted to remove the recommendation for all babies to receive the hepatitis B vaccine at birth. Instead, the panel now advises parents to consult with doctors regarding this vaccination. This represents a significant departure from decades of established practice in the U.S.

Background and Rationale for Previous Recommendation

For many years, the hepatitis B vaccine has been a standard recommendation for all newborns in the United States. Hepatitis B is a serious viral infection that affects the liver and can lead to severe health issues such as cirrhosis and liver cancer. Newborns are particularly susceptible to this blood-borne virus, with a 90% chance of lifelong infection if exposed at birth. The vaccine has proven highly effective in preventing infection when administered within 24 hours of birth.

Dr. Paul Offit, Director of the Vaccine Education Center at Children's Hospital of Philadelphia, explained that the 1991 recommendation for a birth dose for all babies, regardless of their mother's hepatitis B status, was crucial. At that time, approximately 30,000 children under 10 years of age had hepatitis B. Half of these infections were transmitted from mothers, while the other half were acquired through relatively casual contact with individuals who had chronic hepatitis B. Millions of people in the U.S. have chronic hepatitis B, and it can be transmitted through shared personal items like toothbrushes, washcloths, towels, or nail clippers. The birth dose recommendation virtually eliminated hepatitis B in children under 10.

Critique of the New Recommendation

Dr. Offit strongly criticized the new recommendation, stating that it "doesn't recognize" the historical success of the birth dose and "is now trying to put children in harm's way again." He argued that the panel's reasoning, which suggests that the risk to a baby is low and that vaccination should only occur if the mother tests positive for hepatitis B, is not supported by epidemiological data.

Dr. Offit highlighted that in the early 1990s, 15,000 children under 10 contracted hepatitis B not through sexual activity or intravenous drug use, but through casual contact with individuals who had chronic hepatitis B, many of whom were unaware of their infection. He emphasized that testing only the mother is insufficient because it doesn't account for other potential contacts. Therefore, vaccinating all babies at birth is the more reasonable and effective approach. He contrasted this with the period between 1982 and 1991, when the birth dose was only recommended for babies of mothers with hepatitis B, which had minimal impact on the disease in young children. The widespread adoption of the birth dose for all babies in 1991 was what led to a significant impact. Dr. Offit characterized the current committee as an "anti-vaccine, anti-science committee" aiming to revert to a less effective strategy.

Addressing Claims of Vaccine Harm and Autism

The discussion also addressed claims linking the hepatitis B vaccine to autism, particularly those made by Robert F. Kennedy Jr. Dr. Offit unequivocally stated that there is no truth to these claims and that the studies referenced by Kennedy do not support them. He pointed to Kennedy's history of making unsubstantiated claims, including:

• Claiming the measles, mumps, rubella (MMR) vaccine causes autism, as depicted in the movie "Vaxxed II."
• Promoting the idea that thimerosal, a mercury-containing preservative, causes autism, despite numerous studies refuting this.
• Kennedy's announcement that autism is preventable, followed by Donald Trump's claim that Tylenol causes autism, which is also not supported by scientific evidence from studies in Sweden and Japan.

Dr. Offit questioned when Robert F. Kennedy Jr. would lose credibility given these repeated unsubstantiated assertions.

International Vaccination Practices and U.S. Outlier Status

A representative from the FDA presented evidence suggesting that the U.S. is an outlier compared to other developed nations in terms of childhood vaccination rates. Dr. Offit explained that the U.S. prioritizes vaccinating children against diseases that can cause suffering, hospitalization, or death, and is willing to invest in these preventative measures. He contrasted this with some European countries that opt out of certain vaccines, such as the chickenpox vaccine. In the U.S., chickenpox historically led to 10,000 hospitalizations annually and caused 75 to 100 child deaths per year, underscoring the rationale for widespread vaccination.

Concerns Regarding Pharmaceutical Liability and Regulatory Oversight

Aaron Siri, described as a "notorious anti-vaccine lawyer," presented arguments suggesting that pharmaceutical companies, due to liability protections from Congress, do not adequately test vaccines and that federal regulators overlook evidence of harm. Dr. Offit responded that the presence of such individuals testifying before the vaccine panel indicates that the panel is no longer "preeminent" and "not to be trusted." He also expressed a lack of trust in the CDC.

Dr. Offit concluded that Robert F. Kennedy Jr. has effectively elevated anti-vaccine activism to public policy. However, he noted that the broader medical and scientific community largely ignores the ACIP and the CDC. He cited the American Academy of Pediatrics (AAP) as an example, which issued a clear directive recommending the birth dose for all babies, effectively disregarding the actions of the advisory committee. Dr. Offit expressed hope that others will also ignore the committee's recommendations, as they are "worth ignoring."

Conclusion

The shift in the hepatitis B birth dose recommendation by the federal vaccine advisory panel, led by individuals associated with Robert F. Kennedy Jr., marks a significant departure from established public health policy. Dr. Paul Offit strongly advocates for the continuation of the universal birth dose, citing its proven effectiveness in preventing hepatitis B infections in children and refuting claims of vaccine-induced harm, particularly concerning autism. The debate highlights a growing divide between established scientific consensus and emerging anti-vaccine sentiments influencing public health policy.